gene-based risk testing for lung cancer and chronic obstructive pulmonary disease (Synergenz BioScience Inc)
90
Structured Review
Synergenz BioScience Inc
gene-based risk testing for lung cancer and chronic obstructive pulmonary disease
Gene Based Risk Testing For Lung Cancer And Chronic Obstructive Pulmonary Disease, supplied by Synergenz BioScience Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gene-based+risk+testing+for+lung+cancer+and+chronic+obstructive+pulmonary+disease/gene+based+risk+testing+for+lung+cancer+and+chronic+obstructive+pulmonary+disease/pmc06037978-274-21-14
Average 90 stars, based on 1 article reviews
Gene Based Risk Testing For Lung Cancer And Chronic Obstructive Pulmonary Disease, supplied by Synergenz BioScience Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gene-based+risk+testing+for+lung+cancer+and+chronic+obstructive+pulmonary+disease/gene+based+risk+testing+for+lung+cancer+and+chronic+obstructive+pulmonary+disease/pmc06037978-274-21-14
Average 90 stars, based on 1 article reviews
gene-based risk testing for lung cancer and chronic obstructive pulmonary disease - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
other:Article Title: Chronic obstructive pulmonary disease (COPD) and lung cancer screening Article Snippet: Conflicts of Interest : |